BlackRock’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
BlackRock's GDRX Position: Q1 2026 in Review
BlackRock reduced its GoodRx Holdings (GDRX) stake by 6% in Q1 2026, selling an estimated $279K and leaving 1,861,591 shares worth $3.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3947.
BlackRock first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $67.6M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- BlackRock held 1,861,591 shares of GoodRx Holdings worth $3.65M as of Q1 2026.
- BlackRock sold 118,960 GoodRx Holdings shares in Q1 2026, an estimated $279K.
- GoodRx Holdings made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3947 holding.
- BlackRock first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
- BlackRock's GoodRx Holdings position peaked at $67.6M in Q1 2021.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.